Literature DB >> 11064397

Intraperitoneal macrophages and tumor immunity: A review.

P G Jackson1, S R Evans.   

Abstract

The macrophage (Mphi) is considered the first line of defense in immune response to foreign invaders. Increasing evidence suggests that Mphi(s) also play an important role against neoplastic cells. Mphi(s) exposed to supraphysiologic concentrations of CO(2) are suppressed. As surgeons apply newer minimally invasive techniques to oncologic therapies, it is important to evaluate the impact of these techniques on host-tumor interactions. We review the current understanding of Mphi biology with specific attention on cytotoxicity in addition to tumor immunity. Although systemic immune function is better preserved after laparoscopy than laparotomy, peritoneal Mphi(s) show reduced function after CO(2) pneumoperitoneum than exposure to air. Mphi(s) have shown cytotoxicity to syngeneic cancer cells and may play an important role in tumor surveillance. The impairment in Mphi function after CO(2) exposure may have an effect on outcome after oncologic surgery. In our understanding, Mphi(s) help destroy neoplastic cells. As CO(2) impairs Mphi activity, laparoscopy may significantly alter the host-tumor interaction. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11064397     DOI: 10.1002/1096-9098(200010)75:2<146::aid-jso14>3.0.co;2-1

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  21 in total

Review 1.  The increased incidence of intraabdominal infections in laparoscopic procedures: potential causes, postoperative management, and prospective innovations.

Authors:  A K Strickland; R G Martindale
Journal:  Surg Endosc       Date:  2005-06-09       Impact factor: 4.584

Review 2.  Laparoscopy and collagen metabolism.

Authors:  R Rosch; K Junge; M Binnebösel; P Bertram; U Klinge; V Schumpelick
Journal:  Hernia       Date:  2006-12       Impact factor: 4.739

3.  Gas-related impact of pneumoperitoneum on systemic wound healing.

Authors:  R Rosch; K Junge; M Binnebösel; N Mirgartz; U Klinge; V Schumpelick
Journal:  Langenbecks Arch Surg       Date:  2007-01-13       Impact factor: 3.445

4.  Pleural macrophages are the dominant cell population in the thoracic cavity with an inflammatory cytokine profile similar to peritoneal macrophages.

Authors:  Akihiro Shimotakahara; Joachim F Kuebler; Gertrud Vieten; Martin L Metzelder; Claus Petersen; Benno M Ure
Journal:  Pediatr Surg Int       Date:  2007-05       Impact factor: 1.827

Review 5.  Kinase AKT controls innate immune cell development and function.

Authors:  Yan Zhang; Xiao Wang; Hui Yang; Huanrong Liu; Yun Lu; Limei Han; Guangwei Liu
Journal:  Immunology       Date:  2013-10       Impact factor: 7.397

6.  Immune cell populations and cytokine production in spleen and mesenteric lymph nodes after laparoscopic surgery versus conventional laparotomy in mice.

Authors:  Ueli Moehrlen; Anja Lechner; Monika Bäumel; Karin Dostert; Johann Röhrl; Martin Meuli; Daniela N Männel; Jürg Hamacher
Journal:  Pediatr Surg Int       Date:  2012-03-17       Impact factor: 1.827

Review 7.  Immunological challenges and therapies in xenotransplantation.

Authors:  Marta Vadori; Emanuele Cozzi
Journal:  Cold Spring Harb Perspect Med       Date:  2014-04-01       Impact factor: 6.915

8.  Intraperitoneal wound in abdominal surgery.

Authors:  Arman Adam Kahokehr
Journal:  World J Crit Care Med       Date:  2013-02-04

9.  Diclofenac inhibits tumor growth in a murine model of pancreatic cancer by modulation of VEGF levels and arginase activity.

Authors:  Nina Mayorek; Nili Naftali-Shani; Myriam Grunewald
Journal:  PLoS One       Date:  2010-09-15       Impact factor: 3.240

10.  CO(2) pneumoperitoneum increases systemic but not local tumor spread after intraperitoneal murine neuroblastoma spillage in mice.

Authors:  Martin Metzelder; Joachim Kuebler; Akihiro Shimotakahara; Gertrud Vieten; Reinhard von Wasielewski; Benno Manfred Ure
Journal:  Surg Endosc       Date:  2008-02-13       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.